A hypothesis has been proposed that hypermutation in MSI-H CRCs induces neoantigens and tumor infiltrating lymphocytes, a process that is attenuated by the strong expression of the immunosuppressive PD-1 receptor ligand (PD-L1) and several other immunosuppressive ligands [20, 21]. The gene discussed is CD274; the disease is neoplasm.